BVF as of Dec. 31, 2013
Portfolio Holdings for BVF
BVF holds 26 positions in its portfolio as reported in the December 2013 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ligand Pharmaceuticals In (LGND) | 24.2 | $138M | 2.6M | 52.60 | |
| Ironwood Pharmaceuticals (IRWD) | 19.4 | $111M | 9.6M | 11.61 | |
| Exelixis Inc cnv | 8.8 | $50M | 41M | 1.23 | |
| Chemocentryx | 7.9 | $45M | 7.8M | 5.79 | |
| Array BioPharma | 6.6 | $38M | 7.6M | 5.01 | |
| Oncomed Pharmaceuticals | 5.6 | $32M | 1.1M | 29.52 | |
| Targacept | 4.5 | $26M | 6.2M | 4.15 | |
| Rigel Pharmaceuticals | 4.0 | $23M | 7.9M | 2.85 | |
| Oncothyreon | 2.8 | $16M | 9.0M | 1.76 | |
| Cytokinetics (CYTK) | 2.7 | $15M | 2.4M | 6.50 | |
| Qlt | 2.3 | $13M | 2.4M | 5.57 | |
| Array Biopharma Inc note 3.000% 6/0 | 2.2 | $13M | 12M | 1.04 | |
| Receptos | 1.6 | $9.2M | 317k | 28.99 | |
| Regado Biosciences | 1.4 | $7.9M | 1.7M | 4.77 | |
| Five Prime Therapeutics | 1.4 | $7.7M | 461k | 16.79 | |
| Xencor (XNCR) | 1.3 | $7.5M | 820k | 9.14 | |
| ArQule | 1.1 | $6.1M | 2.8M | 2.15 | |
| Palatin Technologies | 0.7 | $3.8M | 5.2M | 0.73 | |
| Bind Therapeutics | 0.4 | $2.3M | 150k | 15.09 | |
| Mirati Therapeutics | 0.4 | $2.2M | 134k | 16.63 | |
| Sophiris Bio | 0.4 | $2.2M | 600k | 3.70 | |
| Regulus Therapeutics | 0.3 | $1.7M | 234k | 7.39 | |
| Kindred Biosciences | 0.1 | $577k | 52k | 11.14 | |
| Transcept Pharmaceuticals | 0.1 | $504k | 150k | 3.36 | |
| Agios Pharmaceuticals (AGIO) | 0.0 | $47k | 197k | 0.24 | |
| Anthera Pharmaceutcls | 0.0 | $17k | 560k | 0.03 |
